Our work on early tumor editing is online now! I would like to thank all my coauthors for this fantastic work! rdcu.be/dRys2

Just published! Check out our study of early immunoediting in breast cancer tumors, led by Dr. Ying Zhang and myself, from Lieberman and Hide (@winhide) laboratories. Paper link: rdcu.be/dRys2 nature.com/articles/s4159… Nature Immunology Read more below (1/6):

Happy to have helped contribute to this work with Dr. Ying Zhang, Pourya Naderi, Haiwei Zhang, Simon, Zhouyihan Li, Bowen Gu, Dian-Jang Lee, Zhibin Zhang, Athanasios Ploumakis, Ming Shi, Prof. Hao Wu, @winhide, and Judy Lieberman! (18/18)

Dr. Ying Zhang and collaborators found that early tumor editing preferentially suppresses innate immune signaling to reduce tumor immunogenicity, which can be reversed by inhibiting DNA methylation. #PKUResearch nature.com/articles/s4159…

Our work offers a better understanding of the critical role of innate immune signaling in shaping tumor immunogenicity, highlighting the importance of targeting innate immune pathways for boosting anti-tumor immunity and immunotherapeutic efficacy.nature.com/articles/s4159…

Study reveals how #cancer outsmarts immunity—and how to potentially turn the tables @bidmchealth @natimmunol medicalxpress.com/news/2024-08-r…

The Wistar Institute No oxygen? No glucose? No problem: Fatty acid catabolism enhances effector CD8+ TILs ow.ly/52uM30f6VdC Preview by Flavell Yale University & co.

Ying Zhang - Ertl lab in Cancer Cell "nhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically....." cell.com/cancer-cell/fu…